Clinical trial
A Randomized, Double-blind, Multi-centered, Placebo-controlled Trial to Examine Effects of Heart-protecting Musk Pill on Clinical Outcome in Patients With Chronic Stable Coronary Artery Disease
NCT01897805 is registered in ClinicalTrials.gov with Shanghai Hutchison Pharmaceuticals Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Multi-centered, Placebo-controlled Trial to Examine Effects of Heart-protecting Musk Pill on Clinical Outcome in Patients With Chronic Stable Coronary Artery Disease
- Lead sponsor
- Shanghai Hutchison Pharmaceuticals Limited
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2011
- Completion date
- December 31, 2015
- Enrollment
- 2,700 (estimated)
- Sites
- 98
Conditions
As the registry lists them; a condition with its own page is linked.